Varicella-zoster virus vaccine is able to evade the T-cell response during the replicative phase of the viral life cycle

Títulos similares

• Viral loads in primary varicella zoster virus infection
  por: Malavige, G, et al.
  Publicado: (2008)
• Immune evasion during varicella zoster virus infection of keratinocytes.
  por: Black, A, et al.
  Publicado: (2009)
• Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus
  por: Crack, L, et al.
  Publicado: (2012)
• Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus.
  por: Crack, L, et al.
  Publicado: (2012)
• Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.
  por: Malavige, G, et al.
  Publicado: (2008)